U.S. markets closed

  • S&P Futures

    4,016.25
    +6.25 (+0.16%)
     

  • Dow Futures

    33,022.00
    -15.00 (-0.05%)
     

  • Nasdaq Futures

    13,364.00
    +48.00 (+0.36%)
     

  • Russell 2000 Futures

    2,258.80
    +6.90 (+0.31%)
     

  • Crude Oil

    61.24
    -0.21 (-0.34%)
     

  • Gold

    1,730.30
    +1.90 (+0.11%)
     

  • Silver

    25.05
    +0.10 (+0.39%)
     

  • EUR/USD

    1.1781
    +0.0001 (+0.01%)
     

  • 10-Yr Bond

    1.6790
    -0.0670 (-3.84%)
     

  • Vix

    17.33
    -2.07 (-10.67%)
     

  • GBP/USD

    1.3845
    +0.0013 (+0.09%)
     

  • USD/JPY

    110.6300
    +0.0470 (+0.04%)
     

  • BTC-USD

    60,128.31
    +686.56 (+1.16%)
     

  • CMC Crypto 200

    1,226.59
    +23.42 (+1.95%)
     

  • FTSE 100

    6,737.30
    +23.67 (+0.35%)
     

  • Nikkei 225

    29,720.62
    +331.75 (+1.13%)
     

Selective Serotonin Reuptake Inhibitors (SSRIs) Market- AbbVie Inc., Apotex Inc., Aurobindo Pharma Ltd., among others to contribute to the market growth|Industry Analysis, Market Trends, Opportunities and Forecast 2025

·4 min read

NEW YORK, April 1, 2021 /PRNewswire/ --

Technavio has announced its latest market research report titled Selective Serotonin Reuptake Inhibitors (SSRIs) Market by Application and Geography - Forecast and Analysis 2021-2025
Technavio has announced its latest market research report titled Selective Serotonin Reuptake Inhibitors (SSRIs) Market by Application and Geography - Forecast and Analysis 2021-2025

The selective serotonin reuptake inhibitors (SSRIs) market is poised to grow by $ 809.73 mn during 2021-2025, progressing at a CAGR of about 4% during the forecast period.

View Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.

Download FREE Sample Report !

The report on the selective serotonin reuptake inhibitors (SSRIs) market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by rising prevalence of mental illnesses. With an increase in mental illnesses, there is a rising need for effective neurological drugs. Among the various neurological drugs available in the market, SSRIs drugs have high therapeutic efficacy.

The selective serotonin reuptake inhibitors (SSRIs) market analysis includes application segment and geography landscape. This study identifies the growing geriatric population as one of the prime reasons driving the selective serotonin reuptake inhibitors (SSRIs) market growth during the next few years. The rising awareness of depression among the geriatric population and the healthcare providers and the increasing availability of SSRI treatment regimes for such patients are supporting the growth of the market.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The selective serotonin reuptake inhibitors (SSRIs) market covers the following areas:
Selective Serotonin Reuptake Inhibitors (SSRIs) Market Sizing
Selective Serotonin Reuptake Inhibitors (SSRIs) Market Forecast
Selective Serotonin Reuptake Inhibitors (SSRIs) Market Analysis
Companies Mentioned

  • AbbVie Inc.

  • Apotex Inc.

  • Aurobindo Pharma Ltd.

  • Cipla Inc.

  • Eli Lilly and Co.

  • GlaxoSmithKline Plc

  • H. Lundbeck AS

  • Lupin Ltd.

  • Pfizer Inc.

  • Takeda Pharmaceutical Co. Ltd.

Related Reports on Health Care Include:

  • Endoscopic Closure Devices Market by Product and Geography - Forecast and Analysis 2021-2025- The endoscopic closure devices market size has the potential to grow by USD 579.00 million during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 6.88%. Get FREE sample report in minutes

  • Marine Pharmaceuticals Market by Product, Source, and Geography - Forecast and Analysis 2021-2025- The marine pharmaceuticals market size has the potential to grow by USD 1.43 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 7.60%. Get FREE sample report in minutes

Key Topics Covered:
Executive Summary

Market Landscape

  • Market ecosystem

  • Value chain analysis

Market Sizing

  • Market definition

  • Market segment analysis

  • Market size 2020

  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces summary

  • Bargaining power of buyers

  • Bargaining power of suppliers

  • Threat of new entrants

  • Threat of substitutes

  • Threat of rivalry

  • Market condition

Market Segmentation by Application

  • Market segments

  • Comparison by Application

  • Depression - Market size and forecast 2020-2025

  • Anxiety and panic disorder - Market size and forecast 2020-2025

  • Other mental conditions - Market size and forecast 2020-2025

  • Market opportunity by Application

Customer landscape

Geographic Landscape

  • Geographic segmentation

  • Geographic comparison

  • North America - Market size and forecast 2020-2025

  • Europe - Market size and forecast 2020-2025

  • Asia - Market size and forecast 2020-2025

  • ROW - Market size and forecast 2020-2025

  • Key leading countries

  • Market opportunity by geography

  • Market drivers

  • Market challenges

  • Market trends

Vendor Landscape

  • Overview

  • Vendor landscape

  • Landscape disruption

Vendor Analysis

  • Vendors covered

  • Market positioning of vendors

  • AbbVie Inc.

  • Apotex Inc.

  • Aurobindo Pharma Ltd.

  • Cipla Inc.

  • Eli Lilly and Co.

  • GlaxoSmithKline Plc

  • H. Lundbeck AS

  • Lupin Ltd.

  • Pfizer Inc.

  • Takeda Pharmaceutical Co. Ltd.

Appendix

  • Scope of the report

  • Currency conversion rates for US$

  • Research methodology

  • List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Report Link: Get FREE Sample Report in Minutes!

Technavio (PRNewsfoto/Technavio)
Technavio (PRNewsfoto/Technavio)
Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/selective-serotonin-reuptake-inhibitors-ssris-market--abbvie-inc-apotex-inc-aurobindo-pharma-ltd-among-others-to-contribute-to-the-market-growthindustry-analysis-market-trends-opportunities-and-forecast-2025-301259378.html

SOURCE Technavio

Recommended Stories

  • Coinbase’s COIN Stock to Go Live on Nasdaq April 14

    The COIN ticker is coming to public markets soon, Coinbase announced Thursday.

  • Options Market Shows Call Bias as Bitcoin Prepares for New Price High

    Bitcoin's call options are drawing higher value than puts.

  • Andreessen Horowitz Leads $4.4M Round in DeFi’s Element Finance

    Element Finance, which is building a yield-maximizing marketplace for crypto interest rates, has landed some prominent backers.

  • USD/JPY Price Forecast – US Dollar Continues Parabolic Move

    The US dollar has rallied yet again during the trading session on Wednesday as this market seems to completely defy gravity.

  • Filecoin Surges 42%, Replaces Litecoin as 9th Largest Digital Asset

    Institutional demand propels filecoin ahead of litecoin.

  • Cathie Wood Storms Back as ARKK, Space Fund Lure $1 Billion

    (Bloomberg) -- A pair of Cathie Wood exchange-traded funds added around $1 billion in a single day this week in an emphatic display of investor loyalty toward the famed Ark Investment Management founder.The flagship Ark Innovation ETF (ticker ARKK) took in a record $717 million on Tuesday, while the Ark Space Exploration and Innovation fund (ARKX) absorbed $281 million on its debut, according to data compiled by Bloomberg.Alongside bumper trading volumes on the day, it all adds up to one of the best-ever ETF launches for the fund, which tracks U.S. and global companies engaged in space exploration and innovation.The launch was seen as a key test of Wood’s appeal after a volatile few months of flows and performance. After one of the strongest performances of 2020, ARKK has dropped 3.7% this year amid a rough patch for tech shares. Before a flood of cash this week, Ark’s main fund had posted five consecutive days of outflows, its longest streak on record.“This is investors taking advantage to jump in after the drop from the top,” said Athanasios Psarofagis, ETF analyst at Bloomberg Intelligence. “You can see some investors were shaken out because there were some days of outflows during this period but for the most part people held strong so the demand is still there.”ARKK was up 3.1% as of 9:41 a.m. in New York on Thursday, while the space fund rose 1.3%.Ark’s investing strategy and success in luring new cash has spurred big bets on small companies, raising concern the firm exerts an outsize influence over the shares its holds. Wood handed fresh ammunition to her critics last week in a filing that removed prospectus clauses limiting exposure and concentration risks in its ETFs.Bearish bets have been building in ARKK, with short interest climbing to 4.9% of shares outstanding, according to data from IHS Markit Ltd, nearing the record 5.3% hit in early March.Still, none of that has taken any shine off the space fund, with Wood’s first new ETF in two years seeing $294 million worth of shares change hands on its first day.The product’s top two holdings are Trimble Inc. and another Ark vehicle, the 3D Printing ETF (PRNT). Other large stakes include Kratos Defense & Security Solutions Inc., L3Harris Technologies Inc. and JD.com Inc., an online retailer in China.(Updates with Thursday trading, short interest details)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Crypto Options Giant Deribit Launches Bitcoin Volatility Index

    The exchange is planning to roll out futures tied to the index soon. It's not a "fear gauge" but an "action gauge."

  • Oil Prices Extend Rally After OPEC+ Throws Another Curveball

    OPEC+ may loosen production restrictions starting next month and continuing into the summer. Oil prices gave up some gains.

  • Stimulus checks coming for some Social Security recipients and other federal beneficiaries, IRS says

    When can Social Security recipients expect third stimulus checks? The IRS projects many COVID payments to be sent electronically by April 7.

  • How many hedge funds are a margin call away from Archegos-style implosion?

    One of the scariest things about Archegos Capital Management’s fall from grace is there could be others. The only reason we know Bill Hwang’s hedge fund had risk up to its eyeballs using borrowed money is because it got caught out by margin calls. “If investment banks didn’t do these margin calls, we probably wouldn’t have seen that,” said Francesc Rodriguez Tous, a finance professor at Cass Business School in London who previously worked at the central banks of England, Germany, and Spain.

  • Five market trends investors are focused on for the second quarter

    The first quarter of 2021 kept investors on their toes as it served up surging yields, an accelerated rotation into cyclical stocks and wild rides in the shares of GameStop that brought the retail investors of WallStreetBets into the public eye. The yield on the benchmark 10-year U.S. Treasury rose by about 80 basis points in the first quarter - the third-largest gain over a 3-month period over the past decade - as investors sold bonds in anticipation of a U.S. economic recovery and higher inflation. Many investors believe the move will continue - Goldman Sachs sees the yield at 1.9% by the end of 2021, while TD Securities expects yields to rise to 2%.

  • German process mining startup Celonis teams up with IBM and Red Hat

    Celonis, a fast-growing German process mining software startup, has struck a strategic partnership with IBM to help companies make the most of the digital transformation that many are undergoing at speed. IBM's Global Business Services consulting arm will weave the Celonis Execution Management System into its offering, adding the ability to analyse data thrown off by processes like supply-chain management, finance or procurement to identify weaknesses and recommend fixes. Celonis will also shift its software stack to IBM's Red Hat OpenShift platform, which enables companies to operate in an open 'hybrid' setting that can include public or private cloud data centres, on-premise servers and mainframe computers.

  • ByteDance says it is 'bleeding' due to India bank account freeze, no relief from court

    An Indian court on Wednesday granted no relief to China's ByteDance, owner of the TikTok video app, in a case where the company challenged the local tax authority's decision to block its Indian bank accounts, dealing a blow to its operations. Indian authorities in mid-March blocked ByteDance's bank accounts for alleged tax evasion, prompting the company to ask a court to quash the directive which it feared would hurt its operations. All bank accounts are frozen.

  • AMC Entertainment Seeks Approval to Sell 500 Million New Shares

    (Bloomberg) -- AMC Entertainment Holdings Inc. is seeking investor approval to issue as many as 500 million new shares, an opportunity for a financial cushion while the theater chain works to draw fans back to the movies.Management doesn’t necessarily intend to sell the new shares immediately, but wants the option to do so, Chief Executive Officer Adam Aron said Thursday in an interview on CNBC. The company announced the effort in a regulatory filing last month.AMC could use the shares to bolster its cash reserve, buy back debt at a discount, settle deferred theater rents or pursue an acquisition, Aron said. The shares have soared over the past six months, benefiting from a Reddit-fueled investing frenzy that sent heavily shorted stocks into the stratosphere.“There are a lot of good reasons for shareholders to give us the authority,” Aron said.Shares of the Leawood, Kansas-based company fell as much as 6.4% to $9.56 in New York. The company’s 12% second-lien notes due 2026 rose more than a cent on the dollar to a high of 82.88 cents, according to Trace bond trading data.AMC has raised more than $1 billion in financing this year, which helped stave off bankruptcy while its theaters were closed because of the coronavirus pandemic. The company said previously it might seek more financing, and some creditors have suggested it sell more shares to pay down debt.Theater chains have been hard hit by government-mandated shutdowns during the Covid-19 pandemic. While the company has been able to reopen all but a small portion of its locations, it’s still operating at limited capacity to ensure extra space for customers, and many moviegoers have been reluctant to attend. The problem has been compounded by studios delaying major releases that drive ticket sales.AMC’s shares traded at historic lows for much of 2020 as the Covid-19 crisis engulfed the company. Management started issuing “going concern” notices last June, warning the company risked running out of cash. The shares have jumped more than 350% this year as a result of Reddit traders and the infusion of fresh capital.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Exxon Mobil signals first profit in five quarters on price gains

    HOUSTON (Reuters) -Exxon Mobil Corp could post its first profit in five quarters on improved results across its businesses, with higher oil and gas prices providing a lift of as much as $2.7 billion, offset by costs from a February deep freeze. The largest U.S. oil producer last year posted consecutive quarterly losses as falling oil prices and refining margins triggered write downs. It slashed operating expenses last year and analysts had forecast a per share profit of 54 cents, according to IBES data from Refinitiv.

  • Crypto Exchange Luno Hires CFO of Digital Banking Giant Monzo

    Alwyn Jones is the latest in a group of digital banking executives to join crypto firms.

  • Greensill insurance mystery turns up the heat on Credit Suisse

    Credit Suisse told investors the debt in its $7.3 billion finance fund was low risk because it was insured but the bank failed to ensure the policies would pay out, two sources told Reuters. When Japan's Tokio Marine, the company insuring the debt, declined to renew its coverage with Greensill Capital last month, Credit Suisse was forced to liquidate the fund and said this may have a material impact on its results and reputation. The bank's shares have fallen by almost a quarter in the past month as it deals with the fallout from Greensill and the impact of losses at its prime brokerage division caused by the stricken U.S. fund Archegos.

  • Toilet paper prices to rise: Maker of Cottonelle, Scott brands plans to increase prices

    Kimberly-Clark, the maker of the Cottonelle, Scott and Viva brands, said Wednesday that it will hike toilet paper prices because of commodity costs.

  • Used-Car Retailer CarMax Q4 Sales to Grow 4%, Earnings to Fall

    The United States’ largest used-car retailer CarMax is expected to report its fourth-quarter earnings of $1.25 per share, which represents a year-over-year decline of about 4% from $1.30 per share seen in the same quarter a year ago; however, sales will likely grow 4% year over year.

  • U.K.’s Giant Battery Factory Developer Looks for a SPAC Deal

    (Bloomberg) -- Britishvolt Ltd., the developer of the first giant battery factory in the U.K., is considering going public.The company has appointed Guggenheim Securities LLC and Barclays Plc as advisers to look into options including listing in the U.S. through a merger with a special purpose acquisition company, or SPAC, Orral Nadjari, founder and chief executive officer of Britishvolt, said in an interview. The deal could be announced as soon as the end of this quarter, he said.It’s the first time the company has talked in detail about its plans to finance the 2.6 billion-pound ($3.6 billion) project that will play a central role in delivering Prime Minister Boris Johnson’s green plan. The U.K. has banned sales of new gasoline and diesel cars by 2030, and needs a factory producing batteries for electric vehicles to avoid falling behind in the global race to lead manufacturing for the energy transition.“The SPAC market is very interesting and is the result of the very mature capital markets in the U.S. that have identified the industrial revolution that is happening now, when we go from the era of internal combustion engine towards an era of electrification,” Nadjari said. “There will be a lot of scale-ups that will need a lot of capital.”The company hasn’t identified any automotive customers yet, and it’s unclear if any automaker will agree on a supply deal with an upstart that’s still seeking funding. Nadjari, a former investment banker, says he’s not worried.By 2040, electric vehicles will make up two-thirds of total passenger car sales in Europe, with more 10 million units sold a year. That will make the continent the second-largest EV market, behind China and ahead of the U.S., according to BloombergNEF.If Britishvolt does agree to a SPAC deal, the target to announce it will be the end of the second quarter or beginning of the third, Nadjari said.Based in Blyth in northeast England, Britishvolt is planning to launch its series B funding round next week to raise as much as 100 million pounds, with Barclays as its financial adviser, Nadjari said. The round already has “a lot of interest” and series C will follow before summer with a cap of 250 million pounds.The series A funding round, which closed in February, made William Harrison, chief executive officer of private equity firm Cathexis Holdings LP, the second-largest shareholder, after Nadjari. Cathexis is the family office of Harrison investing from a low of $3 million in niche EV deals, to more than $100 million when buying established companies or financing infrastructure and real estate, according to its website.Because of its exit from the European Union, the U.K.’s auto industry has little time to localize production of batteries. The Brexit deal reached late in 2020 requires 30% of the content of battery packs for U.K.-built cars to be sourced domestically; the regulation gets tougher in 2024.“The new rules of origin should provide the conditions for the U.K. automotive industry to succeed,” said Stephen Gifford, chief economist at the Faraday Institution, which researches commercial battery developments. “But, to do so, it is now more important than ever that gigafactories are built in the U.K., and quickly, and with well-developed local supply chains.”Ministers are determined for the U.K. to stay in the mix of leading battery-makers in Europe. Johnson has committed 1 billion pounds to help build factories that can produce batteries at scale. Britishvolt has applied for some of the funding and is waiting to hear back.“We have had very fruitful conversations with the government,” Nadjari said. “Definitely government funding is critical for large industrial investment such as Britishvolt.”The Automotive Transformation Fund will likely support one, if not two, giant battery factories, according to the Advanced Propulsion Centre U.K., the non-profit acting as the delivery partner for the funding. The aim is to see the U.K. punch above its weight for battery making compared with the scale of its auto sector.The Faraday Institution estimates the U.K. will need seven giant factories by 2040, each producing 20 gigawatt-hours per year of batteries. Britishvolt is looking at building multiple plants in the U.K., Europe and elsewhere to produce 150 to 200 gigawatt-hours by 2030, Nadjari.“It’s a very exciting period and there is a lot of money in the capital markets looking at ESG propositions,” Nadjari said. “We are uniquely positioned to potentially become the British champion within the energy industry.”(Adds details about government funding in thirteenth paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.